The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Adenosine receptor–dopamine receptor interactions in the basal ganglia and their relevance for brain function
Open accessAbstract
The dopamine D1 and D2 receptors are major receptors in the regulation of striatal function and striatal adenosine A1 and A2A receptors are major modulators of their signaling. The evidence suggests the existence of antagonistic A1-D1 heteromeric receptor complexes in the basal ganglia and prefrontal cortex and especially in the direct striatonigral-striatoentopeduncular GABA pathways. The neurochemical and behavioral findings showing antagonistic A1-D1 receptor interactions can be explained by the existence of such A1-D1 heteromeric receptor complexes and of antagonistic interactions at the level of the second messengers. In contrast, A2A-D2 receptor heteromers may exist in the dorsal and ventral striato-pallidal GABA pathways, where activation of A2A receptors reduces D2 receptor recognition, coupling and signaling. As a result of the A2A receptor-induced reduction of D2 receptor signaling, the activity of these GABA neurons is increased resulting in reduced motor and reward functions mediated via the indirect pathway, causing a reduced glutamate drive to the prefrontal and motor areas of the cerebral cortex. Thus, A2A receptor antagonists and A2A receptor agonists, respectively, may offer novel treatments of Parkinson's disease (reduced D2 receptor signaling) and of schizophrenia and drug addiction (increased D2 receptor signaling).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Self-citationHillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Self-citationDopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Self-citationAdenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K., Fuxe, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432
Self-citationFerré, S., Karcz-Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxe, K., Goldberg, S. R., Lluis, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365
Self-citationAdenosine-dopamine interactions in the brain
Ferré, S., Fuxe, K., von Euler, G., Johansson, B., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 364
Self-citationAgnati, L. F., Ferré, S., Lluis, C., Franco, R., & Fuxe, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 323
Self-citationFuxe, K., Ferré, S., Zoli, M., & Agnati, L. F. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00049-0 · Cited by 280
Self-citationCell surface adenosine deaminase: Much more than an ectoenzyme
Franco, R., Casadó, V., Ciruela, F., Saura, C., Mallol, J., Canela, E. I., & Lluis, C. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00013-0 · Cited by 257
Self-citationThe striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain
Ferre, S., O'Connor, W., Fuxe, K., & Ungerstedt, U. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05402.1993 · Cited by 251
Self-citationFuxe, K., Agnati, L. F., Jacobsen, K., Hillion, J., Canals, M., Torvinen, M., Tinner-Staines, B., Staines, W., Rosin, D., Terasmaa, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000095206.44418.5c · Cited by 248
Self-citationHeteromeric association creates a P2Y-like adenosine receptor
Yoshioka, K., Saitoh, O., & Nakata, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121587098 · Cited by 231
Bibbiani, F., Oh, J. D., Petzer, J. P., Castagnoli, N., Chen, J.-F., Schwarzschild, M. A., & Chase, T. N. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00250-4 · Cited by 204
Ciruela, F., Burgueño, J., Casadó, V., Canals, M., Marcellino, D., Goldberg, S. R., Bader, M., Fuxe, K., Agnati, L. F., Lluis, C., et al. (2004) · Analytical Chemistry · doi:10.1021/ac049295f · Cited by 192
Self-citationDesensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor
Ng, G. Y. K., Mouillac, B., George, S. R., Caron, M., Dennis, M., Bouvier, M., & O'Dowd, B. F. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90219-4 · Cited by 180
Ciruela, F., Escriche, M., Burgueño, J., Angulo, E., Casadó, V., Soloviev, M. M., Canela, E. I., Mallol, J., Chan, W.-Y., Lluis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006960200 · Cited by 180
Self-citationFerré, S., O'Connor, W. T., Snaprud, P., Ungerstedt, U., & Fuxe, K. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90521-5 · Cited by 171
Self-citationFuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 170
Ciruela, F., Saura, C., Canela, E. I., Mallol, J., Lluis, C., & Franco, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00023-3 · Cited by 168
Self-citationCanals, M., Burgueño, J., Marcellino, D., Cabello, N., Canela, E. I., Mallol, J., Agnati, L., Ferré, S., Bouvier, M., Fuxe, K., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02200.x · Cited by 159
Self-citationAdenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
Rimondini, R., Ferré, S., Ogren, S. O., & Fuxe, K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00033-x · Cited by 152
Self-citationCentral adenosine A2A receptors: an overview
Moreau, J., & Huber, G. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00059-4 · Cited by 146
Ferré, S., O'Connor, W. T., Svenningsson, P., Björklund, L., Lindberg, J., Tinner, B., Strömberg, I., Goldstein, M., Ögren, S. O., Ungerstedt, U., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01617.x · Cited by 146
Self-citationKF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activity
Kanda, T., Shiozaki, S., Shimada, J., Suzuki, F., & Nakamura, J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90551-7 · Cited by 145
Postsynaptic antagonistic interaction between adenosine A1, and dopamine D1 receptors
Ferré, S., Popoli, P., Giménez‐Llort, L., Finnman, U.-B., Martı́nez, E., de Carolis, A. S., & Fuxé, K. (1994) · Neuroreport · doi:10.1097/00001756-199412300-00020 · Cited by 138
Self-citationOligomerization of adenosine A2A and dopamine D2 receptors in living cells
Kamiya, T., Saitoh, O., Yoshioka, K., & Nakata, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00991-4 · Cited by 138
Lee, S. P., O’Dowd, B. F., Rajaram, R. D., Nguyen, T., & George, S. R. (2003) · Biochemistry · doi:10.1021/bi0345539 · Cited by 133
Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
Ferré, S., Popoli, P., Giménez‐Llort, L., Rimondini, R., Müller, C. E., Strömberg, I., Ögren, S. O., & Fuxé, K. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00063-8 · Cited by 130
Self-citationQuarta, D., Borycz, J., Solinas, M., Patkar, K. A., Hockemeyer, J., Ciruela, F., Lluı́s, C., Franco, R., Woods, A. S., Goldberg, S. R., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02761.x · Cited by 120
Self-citationDopamine D2 Receptor Dimer Formation
Armstrong, D., & Strange, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006936200 · Cited by 120
Kull, B., Ferré, S., Arslan, G., Svenningsson, P., Fuxé, K., Owman, C., & Fredholm, B. B. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00184-7 · Cited by 118
Self-citationFerré, S., Torvinen, M., Antoniou, K. M., Irenius, E., Civelli, O., Arenas, E., Fredholm, B. B., & Fuxé, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4718 · Cited by 117
Self-citationFerré, S., & Fuxé, K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91036-e · Cited by 103
Self-citationStrömberg, I., Popoli, P., Müller, C. E., Ferré, S., & Fuxé, K. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00288.x · Cited by 85
Self-citationRimondini, R., Ferré, S., Giménez‐Llort, L., Ögren, S. O., & Fuxé, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00107-1 · Cited by 80
Self-citationTanganelli, S., Nielsen, K. S., Ferraro, L., et al. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.015 · Cited by 75
Dı́az-Cabiale, Z., Hurd, Y. L., Guidolin, D., et al. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00014 · Cited by 74
Popoli, P., Giménez‐Llort, L., Pèzzola, A., Reggio, R., Martínez, E., Fuxé, K., & Ferré, S. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13143-8 · Cited by 74
Self-citationAgnati, L. F., Tarakanov, A. O., Ferré, S., Fuxé, K., & Guidolin, D. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:193 · Cited by 73
Self-citationToda, S., Alguacil, L. F., & Kalivas, P. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02121.x · Cited by 69
Combining Mass Spectrometry and Pull-Down Techniques for the Study of Receptor Heteromerization
Burgueñeno, J., Casadó, V., Bäder, M., Goldberg, S. P., Canals, M., Franco, R., Woods, A. S., Ciruela, F., Lluís, C., Fuxe, K., et al. (2004) · Analytical Chemistry · Cited by 62
Self-citationTorvinen, M., Ginés, S., Hillion, J., Latini, S., Canals, M., Ciruela, F., Bordoni, F., Staines, W. A., Pedata, F., Agnati, L. F., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00058-1 · Cited by 57
Self-citationKudlacek, O., Just, H., Korkhov, V. M., Vartian, N., Klinger, M., Pankevych, H., Yang, Q., Nanoff, C., Freissmuth, M., & Boehm, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300181 · Cited by 50
Sommer, W. H., Rimondini, R., O'Connor, W. T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14134 · Cited by 47
Torvinen, M., Kozell, L. B., Neve, K. A., Agnati, L. F., & Fuxé, K. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:173 · Cited by 47
Self-citationAndersen, M. B., Fuxé, K., Werge, T. M., et al. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00005 · Cited by 35
Ferré, S., Rimondini, R., Popoli, P., Reggio, R., Pèzzola, A., Hansson, A. C., Andersson, A., & Fuxé, K. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00810.x · Cited by 32
Self-citationOn the Molecular Basis of the Receptor Mosaic Hypothesis of the Engram
Agnati, L. F., Ferré, S., Leo, G., Lluı́s, C., Canela, E. I., Franco, R., & Fuxé, K. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000023626.35717.5d · Cited by 31
Self-citationPopoli, P., Ferré, S., Pèzzola, A., Reggio, R., de Carolis, A. S., & Fuxé, K. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00242-7 · Cited by 21
Self-citationWu, H., Fuxé, K., & Schwarcz, R. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02531.x · Cited by 13
Cited by
Modulation of Striatal Projection Systems by Dopamine
Gerfen, C. R., & Surmeier, D. J. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113641 · Cited by 1,718
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
Purinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Metadata
- Authors
- Fuxe, K., Ferré, S., Genedani, S., Franco, R., & Agnati, L. F.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 92
- Issue
- 1-2
- Pages
- 210-217
- ISSN
- 0031-9384 (ISSN-L)
- OpenAlex
- W2068153172
- Cited by
- 256
- References
- 51
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.